Accuro Technology: How It’s Different From Traditional Ultrasound

Dr. Will Mauldin, RIVANNA CEO and Co-Founder, saw a need in anesthesia for automated, real-time image guidance for epidurals. That prompted the development of the FDA-approved Accuro Neuraxial Guidance device, an ultrasound-based imaging solution for epidural and spinal anesthesia.

Accuro identifies the spinal midline and interlaminar space with over 94% accuracy. Over 30 clinical studies show that image guidance enables faster, safer, and more efficient needle placement.

That’s more than a need. It’s a necessity.